Business
Join Cannabics Pharmaceuticals at LCBC Cannabis Professional Conference Held at MTCC, Toronto, Canada, May 25-27, 2018
Join Cannabics Pharmaceuticals at LCBC Cannabis Professional Conference Held at MTCC, Toronto, Canada, May 25-27, 2018.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nJoin Cannabics Pharmaceuticals at LCBC Cannabis Professional Conference Held at MTCC, Toronto, Canada, May 25-27, 2018\n\n\n\n\n\nJoin Cannabics Pharmaceuticals at LCBC Cannabis Professional Conference Held at MTCC, Toronto, Canada, May 25-27, 2018\nPR Newswire\nTEL AVIV, Israel and BETHESDA, Maryland, May 24, 2018\n\n\n\nTEL AVIV, Israel and BETHESDA, Maryland, May 24, 2018 /PRNewswire/ --\n\nCannabics Pharmaceuticals (OTCQB: CNBX), a US bio-pharma company developing novel cannabis-based, personalized medicine solutions for anti-cancer diagnostics and treatment will hold one-on-one meetings at Canada's biggest cannabis business Conference  \n\nCannabics Pharmaceuticals (OTCQB: CNBX), a US, public bio-pharma company dedicated to developing precision medicine solutions for personalized anti-cancer diagnostics and palliative cannabis-based treatments, announced today that its management members are to attend The Lift & Co. Expo (LCBC), Canada's biggest professional cannabis business conference, to be held this week at MTCC, Toronto, Canada.\n\n     (Logo: http://mma.prnewswire.com/media/485543/Cannabics_Logo.jpg )\n\n\nCannabics Pharmaceutical's breakthrough technology is based on non-intrusive diagnostic testing for cancer patients, to be employed for selecting the most appropriate and optimal Cannabinoid-based therapies and medications applied to specific patients based on their molecular/cellular screening analysis results.\n\nJoin them in Toronto this week!  \n\nThe company's CEO, Mr. Eyal Barad, will accept one-on-one meetings. \n\nTo schedule meetings and any other inquiry, please contact us at: [email protected] \n\nAbout Cannabics Pharmaceuticals Inc.\n\nCannabics Pharmaceuticals Inc. (CNBX) is a US bio-pharma company dedicated to developing precision medicine personalized anti-cancer diagnostics and cannabis based treatments. It is based on Israeli R&D licensed by the Israeli Ministry of Health for scientific and clinical research. Cannabics novel technology pioneers the assimilation of precision medicine into Cannabinoid-based therapies for cancer patients, utilizing original, patented screening technologies, data management and artificial intelligence (AI).\n\nDisclaimer: \n\nCertain statements contained in this release may constitute forward-looking state...